ABSENCE OF HLA CLASS-I EXPRESSION BY REED-STERNBERG CELLS

被引:0
作者
POPPEMA, S
VISSER, L
机构
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The reactive cell population in Hodgkin's disease consists of predominantly CD4(+) helper T cells and lacks CD8(+) cytotoxic T cells and natural killer cells. This lack of a CD8(+) response is surprising in view of the expression of the Intent Epstein-Barr viral protein LMP by Reed-Sternberg cells in many cases of Hodgkin's disease. Deficient HLA class I expression would be one possible mechanism to avoid a CD8(+) cytotoxic immune response. To test this possibility we studied the expression of HLA class I and II determinants on Reed-Sternberg cells in tissue sections and cell suspensions of Hodgkin's disease. Frozen tissue sections of 40 cases and cytocentrifuge preparations from cell suspensions of to lymph nodes involved by Hodgkin's disease were studied with monoclonal antibodies reactive with HLA determinants. As a control frozen tissue sections of two cases of infectious mononucleosis were studied. Careful examination of the tissue sections and subsequently of cytospins of cell suspensions showed that the Reed-Sternberg cells frequently lacked HLA class I but showed strong staining for HLA class II. Absence of HLA class I expression on Reed-Sternberg cells and their variants provides an explanation for the lack of a CD8(+) cytotoxic immune response against antigens expressed on Reed-Sternberg cells.
引用
收藏
页码:37 / 41
页数:5
相关论文
共 35 条
[1]   ACUTE INFECTIOUS-MONONUCLEOSIS - CD30 (KI-1) ANTIGEN EXPRESSION AND HISTOLOGIC CORRELATIONS [J].
ABBONDANZO, SL ;
SATO, N ;
STRAUS, SE ;
JAFFE, ES .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1990, 93 (05) :698-702
[2]  
AISENBERG AC, 1982, BLOOD, V59, P522
[3]   IMPAIRED INTRACELLULAR-TRANSPORT OF CLASS-I MHC ANTIGENS AS A POSSIBLE MEANS FOR ADENOVIRUSES TO EVADE IMMUNE SURVEILLANCE [J].
ANDERSSON, M ;
PAABO, S ;
NILSSON, T ;
PETERSON, PA .
CELL, 1985, 43 (01) :215-222
[4]   TUMORIGENICITY OF CELLS TRANSFORMED BY ADENOVIRUS-TYPE-12 BY EVASION OF T-CELL IMMUNITY [J].
BERNARDS, R ;
SCHRIER, PI ;
HOUWELING, A ;
BOS, JL ;
VANDEREB, AJ ;
ZIJLSTRA, M ;
MELIEF, CJM .
NATURE, 1983, 305 (5937) :776-779
[5]   ALTERED BINDING OF REGULATORY FACTORS TO HLA CLASS-I ENHANCER SEQUENCE IN HUMAN TUMOR-CELL LINES LACKING CLASS-I ANTIGEN EXPRESSION [J].
BLANCHET, O ;
BOURGE, JF ;
ZINSZNER, H ;
ISRAEL, A ;
KOURILSKY, P ;
DAUSSET, J ;
DEGOS, L ;
PAUL, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (08) :3488-3492
[6]  
BOROWITZ MJ, 1982, CANCER TREAT REP, V66, P667
[7]   DISTRIBUTION OF LYMPHOCYTE-T SUBSETS IN HODGKINS-DISEASE CHARACTERIZED BY MONOCLONAL-ANTIBODIES [J].
DORREEN, MS ;
HABESHAW, JA ;
WRIGLEY, PFM ;
LISTER, TA .
BRITISH JOURNAL OF CANCER, 1982, 45 (04) :491-499
[8]  
ELLIOTT BE, 1989, ADV CANCER RES, V53, P181
[9]   SELECTIVE REJECTION OF H-2-DEFICIENT LYMPHOMA VARIANTS SUGGESTS ALTERNATIVE IMMUNE DEFENSE STRATEGY [J].
KARRE, K ;
LJUNGGREN, HG ;
PIONTEK, G ;
KIESSLING, R .
NATURE, 1986, 319 (6055) :675-678
[10]   LOCALIZATION OF EPSTEIN-BARR-VIRUS CYTOTOXIC T-CELL EPITOPES USING RECOMBINANT VACCINIA - IMPLICATIONS FOR VACCINE DEVELOPMENT [J].
KHANNA, R ;
BURROWS, SR ;
KURILLA, MG ;
JACOB, CA ;
MISKO, IS ;
SCULLEY, TB ;
KIEFF, E ;
MOSS, DJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (01) :169-176